| Date Filed | Type | Description |
| 10/03/2023 |
4
| Christianson Mark (Business Development Director) has filed a Form 4 on NEUROONE MEDICAL TECHNOLOGIES Corp|
Txns:
| Paid exercise price by delivering 90 shares
@ $0.8904, valued at
$80.1 |
|
| 08/01/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 07/05/2023 |
4
| Christianson Mark (Business Development Director) has filed a Form 4 on NEUROONE MEDICAL TECHNOLOGIES Corp|
Txns:
| Paid exercise price by delivering 90 shares
@ $1.2, valued at
$108 |
|
| 06/01/2023 |
4
| Christianson Mark (Business Development Director) has filed a Form 4 on NEUROONE MEDICAL TECHNOLOGIES Corp|
Txns:
| Paid exercise price by delivering 90 shares
@ $1.21, valued at
$108.9 |
|
| 04/25/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 04/04/2023 |
4
| Christianson Mark (Business Development Director) has filed a Form 4 on NEUROONE MEDICAL TECHNOLOGIES Corp|
Txns:
| Paid exercise price by delivering 90 shares
@ $1.61, valued at
$144.9 |
|
| 03/24/2023 |
4
| Christianson Mark (Business Development Director) has filed a Form 4 on NEUROONE MEDICAL TECHNOLOGIES Corp|
Txns:
| Sold 2,122 shares
@ $1.6048, valued at
$3.4k
Sold 11,667 shares
@ $1.5085, valued at
$17.6k
Sold 12,711 shares
@ $1.502, valued at
$19.1k
|
|
| 02/07/2023 |
4
| Christianson Mark (Business Development Director) has filed a Form 4 on NEUROONE MEDICAL TECHNOLOGIES Corp|
Txns:
| Paid exercise price by delivering 2,175 shares
@ $1.47, valued at
$3.2k
|
|
| 02/04/2022 |
4
| Christianson Mark (Business Development Director) has filed a Form 4 on NEUROONE MEDICAL TECHNOLOGIES Corp|
Txns:
| Granted 15,000 shares
@ $0 |
|
| 02/04/2022 |
4/A
| Christianson Mark (Business Development Director) has filed a Form 4 on NEUROONE MEDICAL TECHNOLOGIES Corp|
Txns:
| Sold 11,300 shares
@ $6.7434, valued at
$76.2k
Sold 600 shares
@ $6.3, valued at
$3.8k
|
|
| 06/25/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/16/2020 |
4
| Christianson Mark (VP of Market Development) has filed a Form 4 on NEUROONE MEDICAL TECHNOLOGIES Corp|
Txns:
| Sold 334,000 shares
@ $0.6, valued at
$200.4k
|
|
| 07/26/2017 |
SC 13D
| Form SC 13D - General statement of acquisition of beneficial ownership: |
| 07/24/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 07/24/2017 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |